Davis, Myrtle
Bristol-Myers Squibb (United States)
3 papers on CoChat
Most cited papers
- Verified
Microphysiological lung models to evaluate the safety of new pharmaceutical modalities: a biopharmaceutical perspective
Ainslie, G. R., Davis, M., Ewart, L., Lieberman, L. A., Rowlands, D. J., Thorley, A. J., Yoder, G., & Ryan, A. M. (2019) · Lab on a Chip
3D Printing in Biomedical ResearchAnimal testing and alternatives
Cited by 65
- Verified
Microphysiological Systems Evaluation: Experience of TEX-VAL Tissue Chip Testing Consortium
Rusyn, I., Sakolish, C., Kato, Y., Stephan, C., Vergara, L., Hewitt, P., Bhaskaran, V., Davis, M., Hardwick, R. N., Ferguson, S. S., et al. (2022) · Toxicological Sciences
3D Printing in Biomedical ResearchAnimal testing and alternatives
Cited by 43
- Verified
Mechanism of hepatobiliary toxicity of the LPA1 antagonist BMS-986020 developed to treat idiopathic pulmonary fibrosis: contrasts with BMS-986234 and BMS-986278
Gill, M. W., Murphy, B. J., Cheng, P. T. W., Sivaraman, L., Davis, M., & Lehman-McKeeman, L. (2022) · Toxicology and Applied Pharmacology
Drug-Induced Hepatotoxicity and ProtectionDrug Transport and Resistance Mechanisms
Cited by 41
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free